Minerva Advisors LLC Immucell Corp Transaction History

Minerva Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jan 31, 2024	BUY	$4.85 - $7.84 $57,996 - $93,750	11,958 New	11,958 $61,000
Q4 2022 Jan 31, 2024	BUY	$6.09 - $8.25 $72,824 - $98,653	11,958 New	11,958 $72,000
Q1 2021 May 12, 2021	SELL	$5.98 - $11.88 $15,553 - $30,899	-2,601 Reduced 17.87%	11,958 $113,000
Q3 2017 Nov 14, 2017	BUY	$5.44 - $7.7 $79,200 - $112,104	14,559	14,559 $93,000

1.15M

Ticker ICCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,746,860
Market Cap $28.7M
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...

Get notified when there are updates to the investment portfolio of Minerva Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Minerva Advisors LLC with notifications on news.